Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dl-amphetamine Sulfate
2. Amphetamine Sulphate
3. Phenaminum
4. 60-13-9
5. Amphamine Sulfate
6. Amphetamini Sulfas
7. Dl-phenamine Sulfate
8. Dl-amphetamine Sulphate
9. Amphetaminium Sulfuricum
10. Desoxynorephedrine Sulfate
11. (+-)-amphetamine Sulfate
12. Dl-amphetamine Hydrogen Sulfate
13. (+-)-phenisopropylamine Sulfate
14. Amfetamine Sulfate
15. Amphetamine Sulfate [usp]
16. Dl-1-phenyl-2-aminopropane Sulfate
17. (+-)-2-amino-1-phenylpropane Sulfate
18. (+-)-alpha-methylphenethylamine Sulfate (2:1)
19. 6dpv8nk46s
20. 1-phenylpropan-2-amine Sulfate (2:1)
21. Amphetamine Sulfate (usp)
22. Fenopromin Sulfate
23. Penamine (van)
24. Ccris 3644
25. 1-phenyl-2-aminopropane Sulfate
26. Cerm 1767
27. Razemisches Phenylaminopropansulfat
28. Dl-alpha-methylphenethylamine Sulfate
29. Einecs 200-457-8
30. Unii-6dpv8nk46s
31. Nsc 170999
32. Dl-amphetamine Sulfate Salt
33. Benzadrine
34. Alpha-methylphenethylamine Sulfate, (+-)-
35. Benzedrine (tn)
36. Evekeo (tn)
37. Evekeo Odt
38. Rac-amphetamine Sulphate
39. D-amphetamine Sulfate Salt
40. Schembl41204
41. Amphetamine Sulfate [mi]
42. Dtxsid4020082
43. Phenethylamine, Alpha-methyl-, Sulfate (2:1), (+-)-
44. Chebi:51063
45. Amfetamine Sulfate [mart.]
46. Amphetamine Sulfate [vandf]
47. Amfetamine Sulfate [who-dd]
48. Bis{1-phenylpropan-2-amine} Sulfate
49. Amfetamine Sulfate [ep Impurity]
50. Amfetamine Sulfate [ep Monograph]
51. Amphetamine Sulfate [orange Book]
52. .beta.-phenylisopyropylaminesulfate
53. Benzeneethanamine, Alpha-methyl-, Sulfate
54. Amphetamine Sulfate [usp Monograph]
55. Amfetamine Sulfate [incb:green List]
56. Delcobese Component Amphetamine Sulfate
57. D02074
58. (+/-)-2-amino-1-phenylpropane Sulfate
59. (+/-)-2-amino-1-phenylpropane Sulphate
60. Amphetamine Sulfate Component Of Delcobese
61. Q21270844
62. (+/-)-.alpha.-methylphenethylamine Sulfate (2:1)
63. (+/-)-.alpha.-methylphenethylamine Sulphate (2:1)
64. Benzeneethanamine, .alpha.-methyl-, Sulfate (2:1), (+/-)-
65. Benzeneethanamine, .alpha.-methyl-, Sulphate (2:1), (+/-)-
66. Dl-amphetamine Sulfate Salt Solution, Drug Standard, 1.0 Mg/ml In Methanol
67. 2-(tetrahydro-furan-2-yl)-n-(3-trifluoromethyl-phenyl)-succinamicacid
68. 156-31-0
1. Amfetamine
2. Mydrial
3. Desoxynorephedrine
4. L Amphetamine
Molecular Weight | 368.5 g/mol |
---|---|
Molecular Formula | C18H28N2O4S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 368.17697855 g/mol |
Monoisotopic Mass | 368.17697855 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 166 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14783
Submission : 2000-03-17
Status : Active
Type : II
NDC Package Code : 49812-0058
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CA |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15089
Submission : 2000-10-13
Status : Active
Type : II
NDC Package Code : 49812-0059
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 23583
Submission : 2010-03-04
Status : Active
Type : II
Available Reg Filing : CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 24048
Submission : 2010-07-08
Status : Active
Type : II
Available Reg Filing : CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-08-04
Pay. Date : 2015-08-27
DMF Number : 29601
Submission : 2016-02-25
Status : Active
Type : II
NDC Package Code : 0792-3939
Start Marketing Date : 2023-11-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-05-24
Pay. Date : 2015-08-27
DMF Number : 29604
Submission : 2016-02-25
Status : Active
Type : II
NDC Package Code : 0792-3936
Start Marketing Date : 2022-12-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-22
Pay. Date : 2023-11-03
DMF Number : 38836
Submission : 2023-10-20
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-03-17
Pay. Date : 2013-03-11
DMF Number : 15385
Submission : 2001-04-18
Status : Active
Type : II
Certificate Number : R0-CEP 2020-076 - Rev 00
Issue Date : 2021-07-26
Type : Chemical
Substance Number : 2752
Status : Valid
NDC Package Code : 0406-9450
Start Marketing Date : 2025-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-08
Pay. Date : 2013-05-31
DMF Number : 15425
Submission : 2001-05-09
Status : Active
Type : II
NDC Package Code : 0406-9451
Start Marketing Date : 2025-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5378
Submission : 1984-02-09
Status : Inactive
Type : II
NDC Package Code : 49812-0058
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49812-0059
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1942
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1971
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61960-0200
Start Marketing Date : 2017-09-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65392-0110
Start Marketing Date : 2018-04-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65392-0114
Start Marketing Date : 2001-10-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1950
Start Marketing Date : 2013-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-9450
Start Marketing Date : 2025-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-9451
Start Marketing Date : 2025-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the mult...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biot...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
dl-1-Chloro-1-phenyl-2-aminopropane Hydrochloride
CAS Number : 25394-33-6
End Use API : Amphetamine Sulfate
About The Company : Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufa...
CAS Number : 3182-95-4
End Use API : Amphetamine Sulfate
About The Company : PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipi...
Phenyl Acetone OR 1-Phenyl-2-Peopanone
CAS Number : 103-79-7
End Use API : Amphetamine Sulfate
About The Company : Maisuriya Pharma Solutions is a research-driven & technology-oriented company. Continuous innovations & improvement are the lifeblood of our business. Our major...
Regulatory Info :
Registration Country : India
Brand Name : Amphetamine
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 5MG
Brand Name : Amphetamine
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Amphetamine
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 10MG
Brand Name : Amphetamine
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Amphetamine
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 15MG
Brand Name : Amphetamine
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Extended Release Capsu...
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 5MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Extended Release Capsu...
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 10MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Extended Release Capsu...
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 25MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Extended Release Capsu...
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 30MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Immediate Release Tabl...
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 5MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Immediate Release Tabl...
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 10MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Immediate Release Tabl...
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 20MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Company : Teva USA
Dextroamphetamine/Amphetamine
Drug Cost (USD) : 9,672,998
Year : 2023
Prescribers : 4019
Prescriptions : 15123
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Takeda Pharmace
Dextroamphetamine/Amphetamine
Drug Cost (USD) : 17,043,346
Year : 2023
Prescribers : 14292
Prescriptions : 53604
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Neos Brands/Ayt
Amphetamine
Drug Cost (USD) : 1,168,346
Year : 2023
Prescribers : 466
Prescriptions : 1972
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amneal Pharmace
Amphetamine Sulfate
Drug Cost (USD) : 85,954
Year : 2023
Prescribers : 102
Prescriptions : 391
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Dr.Reddy'S Lab
Amphetamine Sulfate
Drug Cost (USD) : 22,854
Year : 2023
Prescribers : 42
Prescriptions : 106
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Granules Pharma
Amphetamine Sulfate
Drug Cost (USD) : 48,835
Year : 2023
Prescribers : 81
Prescriptions : 227
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Lannett Co. Inc
Amphetamine Sulfate
Drug Cost (USD) : 24,741
Year : 2023
Prescribers : 32
Prescriptions : 108
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amneal Pharmace
Dextroamphetamine Sulfate
Drug Cost (USD) : 2,315,274
Year : 2023
Prescribers : 160
Prescriptions : 1045
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Aurobindo Pharm
Dextroamphetamine Sulfate
Drug Cost (USD) : 56,605
Year : 2023
Prescribers : 682
Prescriptions : 958
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : KVK-Tech, Inc.
Dextroamphetamine Sulfate
Drug Cost (USD) : 374,982
Year : 2023
Prescribers : 2342
Prescriptions : 4395
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : DISCN
Medice Arzneimittel Pütter GmbH & ...
Dosage Form : Antic-calc Tablet
Dosage Strength : 10 mg
Price Per Pack (Euro) : 62.062
Published in :
Country : Norway
RX/OTC/DISCN :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Medice Arzneimittel Pütter GmbH & ...
Dosage Form : Antic-calc Tablet
Dosage Strength : 20 mg
Price Per Pack (Euro) : 92.851
Published in :
Country : Norway
RX/OTC/DISCN :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Medice Arzneimittel Pütter GmbH & ...
Dosage Form : Antic-calc Tablet
Dosage Strength : 5 mg
Price Per Pack (Euro) : 35.431
Published in :
Country : Norway
RX/OTC/DISCN :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 190
2018 Revenue in Millions : 0
Growth (%) : N/A
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 215
2019 Revenue in Millions : 194
Growth (%) : 11
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 171
2020 Revenue in Millions : 207
Growth (%) : -11
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 184
2021 Revenue in Millions : 171
Growth (%) : 8
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 305
2022 Revenue in Millions : 184
Growth (%) : 87
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 207
2023 Revenue in Millions : 304
Growth (%) : -32
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 364
2015 Revenue in Millions : 363
Growth (%) : 0
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Amphetamine, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 348
2016 Revenue in Millions : 364
Growth (%) : -4
Mixed Salts of a Single-Entity Amphetamine
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 22
2016 Revenue in Millions : 0
Growth (%) : New Launch
Market Place
Reply
30 Apr 2025
Reply
19 Jul 2024
Reply
18 Apr 2024
Reply
30 May 2023
Reply
23 Sep 2022
Reply
30 Sep 2021
Reply
20 Aug 2021
Reply
17 Dec 2020
Reply
20 Jun 2024
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
CAS Number : 22148-75-0
Quantity Per Vial :
Sale Unit :
Price :
Details : N-formylamphetamine
Monograph : 51634-2040
Storage :
Code/Batch No :
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
CAS Number : 60-13-9
Quantity Per Vial :
Sale Unit :
Price :
Details : USP Impurity
Monograph : 51634-2024
Storage :
Code/Batch No :
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
Dextroamphetamine Sulfate (CII)
CAS Number : 51-63-8
Quantity Per Vial :
Sale Unit :
Price :
Details : USP Impurity
Monograph : 51634-2022
Storage :
Code/Batch No :
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
Dextroamphetamine Sulfate, < 98% EE (CII)
CAS Number : 51-63-8
Quantity Per Vial :
Sale Unit :
Price :
Details :
Monograph : 51634-2022
Storage :
Code/Batch No :
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details :
Monograph :
Storage :
Code/Batch No : 730
Dextroamphetamine Related Compound A (25 mg) ...
CAS Number : 698-87-3
Quantity Per Vial : 25
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1180015 / F0H131
Dextroamphetamine Related Compound B CII (25 ...
CAS Number : 103-79-7
Quantity Per Vial : 25
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1180026 / R097P0
Dextroamphetamine Sulfate CII (500 mg)
CAS Number : 51-63-8
Quantity Per Vial : 500
Sale Unit : mg
Price : $340.00
Details : Material Origin- Chemical Synthesis; USMCA- Y...
Monograph :
Storage :
Code/Batch No : Catalog #1180004 / R102M0
ABOUT THIS PAGE
54
PharmaCompass offers a list of Amphetamine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amphetamine Sulfate manufacturer or Amphetamine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amphetamine Sulfate manufacturer or Amphetamine Sulfate supplier.
PharmaCompass also assists you with knowing the Amphetamine Sulfate API Price utilized in the formulation of products. Amphetamine Sulfate API Price is not always fixed or binding as the Amphetamine Sulfate Price is obtained through a variety of data sources. The Amphetamine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A dl-alpha-Methylphenethylamine sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of dl-alpha-Methylphenethylamine sulfate, including repackagers and relabelers. The FDA regulates dl-alpha-Methylphenethylamine sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. dl-alpha-Methylphenethylamine sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of dl-alpha-Methylphenethylamine sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A dl-alpha-Methylphenethylamine sulfate supplier is an individual or a company that provides dl-alpha-Methylphenethylamine sulfate active pharmaceutical ingredient (API) or dl-alpha-Methylphenethylamine sulfate finished formulations upon request. The dl-alpha-Methylphenethylamine sulfate suppliers may include dl-alpha-Methylphenethylamine sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of dl-alpha-Methylphenethylamine sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A dl-alpha-Methylphenethylamine sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of dl-alpha-Methylphenethylamine sulfate active pharmaceutical ingredient (API) in detail. Different forms of dl-alpha-Methylphenethylamine sulfate DMFs exist exist since differing nations have different regulations, such as dl-alpha-Methylphenethylamine sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A dl-alpha-Methylphenethylamine sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. dl-alpha-Methylphenethylamine sulfate USDMF includes data on dl-alpha-Methylphenethylamine sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The dl-alpha-Methylphenethylamine sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of dl-alpha-Methylphenethylamine sulfate suppliers with USDMF on PharmaCompass.
A dl-alpha-Methylphenethylamine sulfate CEP of the European Pharmacopoeia monograph is often referred to as a dl-alpha-Methylphenethylamine sulfate Certificate of Suitability (COS). The purpose of a dl-alpha-Methylphenethylamine sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of dl-alpha-Methylphenethylamine sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of dl-alpha-Methylphenethylamine sulfate to their clients by showing that a dl-alpha-Methylphenethylamine sulfate CEP has been issued for it. The manufacturer submits a dl-alpha-Methylphenethylamine sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a dl-alpha-Methylphenethylamine sulfate CEP holder for the record. Additionally, the data presented in the dl-alpha-Methylphenethylamine sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the dl-alpha-Methylphenethylamine sulfate DMF.
A dl-alpha-Methylphenethylamine sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. dl-alpha-Methylphenethylamine sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of dl-alpha-Methylphenethylamine sulfate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing dl-alpha-Methylphenethylamine sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for dl-alpha-Methylphenethylamine sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture dl-alpha-Methylphenethylamine sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain dl-alpha-Methylphenethylamine sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a dl-alpha-Methylphenethylamine sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of dl-alpha-Methylphenethylamine sulfate suppliers with NDC on PharmaCompass.
dl-alpha-Methylphenethylamine sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of dl-alpha-Methylphenethylamine sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right dl-alpha-Methylphenethylamine sulfate GMP manufacturer or dl-alpha-Methylphenethylamine sulfate GMP API supplier for your needs.
A dl-alpha-Methylphenethylamine sulfate CoA (Certificate of Analysis) is a formal document that attests to dl-alpha-Methylphenethylamine sulfate's compliance with dl-alpha-Methylphenethylamine sulfate specifications and serves as a tool for batch-level quality control.
dl-alpha-Methylphenethylamine sulfate CoA mostly includes findings from lab analyses of a specific batch. For each dl-alpha-Methylphenethylamine sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
dl-alpha-Methylphenethylamine sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (dl-alpha-Methylphenethylamine sulfate EP), dl-alpha-Methylphenethylamine sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (dl-alpha-Methylphenethylamine sulfate USP).